Dysregulation of miR‐543 in Parkinson's disease: Impact on the neuroprotective gene SIRT1
暂无分享,去创建一个
[1] R. Wu,et al. The role of noncoding RNAs in Parkinson’s disease: biomarkers and associations with pathogenic pathways , 2021, Journal of Biomedical Science.
[2] Xiaochen Bo,et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data , 2021, Innovation.
[3] W. L. Lim,et al. MicroRNA Dysregulation in Parkinson’s Disease: A Narrative Review , 2021, Frontiers in Neuroscience.
[4] Min Li,et al. Resveratrol in Rodent Models of Parkinson’s Disease: A Systematic Review of Experimental Studies , 2021, Frontiers in Pharmacology.
[5] M. Wael.,et al. MicroRNA expression changes in Parkinson's disease (PD) patients' leukocytes prior to and following deep brain stimulation (DBS). , 2021, American journal of neurodegenerative disease.
[6] Xuan Li,et al. The Critical Role of SIRT1 in Parkinson’s Disease: Mechanism and Therapeutic Considerations , 2020, Aging and disease.
[7] H. Berendse,et al. Neuropathological correlates of parkinsonian disorders in a large Dutch autopsy series , 2020, Acta Neuropathologica Communications.
[8] Fei Wang,et al. miRTarBase 2020: updates to the experimentally validated microRNA–target interaction database , 2019, Nucleic Acids Res..
[9] Yan Liu,et al. miRNA-384-5p regulates the progression of Parkinson's disease by targeting SIRT1 in mice and SH-SY5Y cells , 2019, International journal of molecular medicine.
[10] A. R. Anwar,et al. Alterations in White Matter Network and Microstructural Integrity Differentiate Parkinson’s Disease Patients and Healthy Subjects , 2019, Front. Aging Neurosci..
[11] F. Tan,et al. Regulatory Mechanism of miR-543-3p on GLT-1 in a Mouse Model of Parkinson's Disease. , 2019, ACS chemical neuroscience.
[12] J. D. Mills,et al. Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence , 2018, Brain pathology.
[13] Carsten Sticht,et al. miRWalk: An online resource for prediction of microRNA binding sites , 2018, PloS one.
[14] A. Corbett. Post-transcriptional regulation of gene expression and human disease. , 2018, Current opinion in cell biology.
[15] F. Hirth,et al. Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease , 2018, Front. Neurosci..
[16] H. Kawano,et al. Interactions between Sirt1 and MAPKs regulate astrocyte activation induced by brain injury in vitro and in vivo , 2017, Journal of Neuroinflammation.
[17] L. Pihlstrøm,et al. [Parkinson's disease and parkinsonism]. , 2017, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.
[18] Peter Bankhead,et al. QuPath: Open source software for digital pathology image analysis , 2017, Scientific Reports.
[19] Gene W Yeo,et al. Pairing beyond the Seed Supports MicroRNA Targeting Specificity. , 2016, Molecular cell.
[20] T. Beach,et al. microRNA Profiles in Parkinson's Disease Prefrontal Cortex , 2016, Front. Aging Neurosci..
[21] Wei Gao,et al. miR-543 promotes gastric cancer cell proliferation by targeting SIRT1. , 2016, Biochemical and biophysical research communications.
[22] Wei Zhao,et al. Down-regulation of the miR-543 alleviates insulin resistance through targeting the SIRT1. , 2015, Biochemical and biophysical research communications.
[23] G. Deuschl,et al. MDS clinical diagnostic criteria for Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[24] D. Bartel,et al. Predicting effective microRNA target sites in mammalian mRNAs , 2015, eLife.
[25] W. Huber,et al. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.
[26] V. Álvarez,et al. MiRNA Profile in the Substantia Nigra of Parkinson’s Disease and Healthy Subjects , 2014, Journal of Molecular Neuroscience.
[27] Vincenzo Bonifati,et al. Effect of resveratrol on mitochondrial function: implications in parkin-associated familiar Parkinson's disease. , 2014, Biochimica et biophysica acta.
[28] Björn Usadel,et al. Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..
[29] Hui Zhou,et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data , 2013, Nucleic Acids Res..
[30] Ana Kozomara,et al. miRBase: annotating high confidence microRNAs using deep sequencing data , 2013, Nucleic Acids Res..
[31] Wei Shi,et al. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..
[32] V. Kim,et al. Regulation of microRNA biogenesis , 2014, Nature Reviews Molecular Cell Biology.
[33] Sterling C. Johnson,et al. White Matter Microstructural Integrity and Executive Function in Parkinson's Disease , 2013, Journal of the International Neuropsychological Society.
[34] E. Katunina,et al. [Epidemiology of Parkinson's disease]. , 2013, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.
[35] Bronwen L. Aken,et al. GENCODE: The reference human genome annotation for The ENCODE Project , 2012, Genome research.
[36] D. Dickson. Parkinson's disease and parkinsonism: neuropathology. , 2012, Cold Spring Harbor perspectives in medicine.
[37] J. Kordower,et al. Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease. , 2012, Brain : a journal of neurology.
[38] G. Pasinetti. Role of Personalized Medicine in the Identification and Characterization of Parkinson's Disease in Asymptomatic Subjects. , 2012, Journal of Alzheimer's disease & Parkinsonism.
[39] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[40] S. Vasudevan. Posttranscriptional Upregulation by MicroRNAs , 2012, Wiley interdisciplinary reviews. RNA.
[41] Steven L Salzberg,et al. Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.
[42] L. Guarente,et al. SIRT1 Protects against α-Synuclein Aggregation by Activating Molecular Chaperones , 2012, The Journal of Neuroscience.
[43] Hui Zhou,et al. starBase: a database for exploring microRNA–mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data , 2010, Nucleic Acids Res..
[44] Xavier Robin,et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves , 2011, BMC Bioinformatics.
[45] Thomas Gasser,et al. Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria , 2009, The Lancet Neurology.
[46] Stijn van Dongen,et al. miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..
[47] G. Levy,et al. The relationship of Parkinson disease with aging. , 2007, Archives of neurology.
[48] E. Lai,et al. Non-motor Symptoms of Parkinson's Disease , 2007 .
[49] A. Chiarugi,et al. The emerging therapeutic potential of sirtuin-interacting drugs: from cell death to lifespan extension. , 2005, Trends in pharmacological sciences.
[50] A. Moorman,et al. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data , 2003, Neuroscience Letters.
[51] L. Guarente,et al. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase , 2000, Nature.